Tumor cells undergoing TGFβ-induced EMT exhibit increased resistance to therapies including chemotherapy and radiation, establishing a correlation between high TGFβ levels and unfavorable prognosis (Zheng et al., 2015). This evidence concerns the gene TGFB1 and neoplasm.